NASDAQ:OM Outset Medical Q3 2026 Earnings Date & Estimates $4.08 -0.02 (-0.49%) Closing price 04:00 PM EasternExtended Trading$4.08 0.00 (0.00%) As of 05:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Outset Medical is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Outset Medical in Q3 2026Outset Medical is expected to post earnings of -$0.64 per share on revenue of $31.40 million. Outset Medical last reported on August 6, 2026, posting -$0.80 per share and missing the -$0.7167 consensus estimate. Outset Medical has beaten the consensus EPS estimate in 0 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.64Expected Revenue$31.40 millionRecent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.80 (Missed by -$0.0833)Last Quarter Revenue$31.64 millionEPS Beat Rate0 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ1 2025 Earnings Report Outset Medical Q3 2026 Earnings FAQ When does Outset Medical report Q3 2026 earnings? Outset Medical (NASDAQ:OM) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Outset Medical's Q3 2026 earnings call? Outset Medical's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Outset Medical? Analysts expect Outset Medical to post earnings of -$0.64 per share for Q3 2026. How much revenue is Outset Medical expected to report? The consensus revenue estimate for Outset Medical is $31.40 million for Q3 2026. Outset Medical Earnings HeadlinesOutset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026October 21, 2026 | globenewswire.comOutset Medical (OM) Gets a Hold from RBC CapitalOctober 16, 2026 | theglobeandmail.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system.October 26 at 1:00 AM | Banyan Hill Publishing (Ad)Outset Medical Announces Departure of General Counsel BrottemAugust 28, 2026 | tipranks.comOutset Medical Earnings Call Highlights Refresh TailwindsAugust 18, 2026 | tipranks.comOutset Medical (OM) Q2 2026 Earnings Call TranscriptAugust 14, 2026 | finance.yahoo.comSee More Outset Medical Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Outset Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Outset Medical and other key companies, straight to your email. Email Address About Outset MedicalOutset Medical (NASDAQ:OM) is a medical technology company that develops products for hemodialysis, a treatment that filters waste and excess fluid from the blood when the kidneys are no longer able to do so adequately. The company’s primary product is the Tablo Hemodialysis System, an integrated dialysis platform designed to simplify treatment for healthcare providers and support broader use of dialysis in hospitals, outpatient facilities and the home. The Tablo system combines dialysis delivery, water purification and dialysate production in a single device and uses a touchscreen interface intended to guide users through treatment setup and operation. Outset also provides related products and services, including disposable treatment supplies, software and technical support associated with the Tablo platform. Outset Medical was founded in 2003 and is headquartered in San Jose, California. Its products have primarily been marketed in the United States, serving acute-care hospitals, outpatient dialysis providers and home-care settings. The company’s stated focus is to make dialysis more accessible and easier to administer through simpler equipment and a more flexible treatment model.View Outset Medical ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure GiantsBristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own StockBuy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big CatalystsComfort Systems Earnings: AI Slowdown or More Growth Ahead?MarketBeat Week in Review – 10/19 - 10/23Amex Stock Slides on Job Cuts, But the Real Story Is MacroBloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline Upcoming Earnings Hilton Worldwide (10/27/2026)Royal Caribbean Cruises (10/27/2026)CocaCola (10/27/2026)Baker Hughes (10/27/2026)ONEOK (10/27/2026)Robinhood Markets (10/27/2026)HSBC (10/27/2026)S&P Global (10/27/2026)Visa (10/27/2026)HCA Healthcare (10/27/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
